These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27910075)

  • 21. IPF, comorbidities and management implications.
    Vancheri C; Cottin V; Kreuter M; Hilberg O
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic pulmonary fibrosis.
    Adkins JM; Collard HR
    Semin Respir Crit Care Med; 2012 Oct; 33(5):433-9. PubMed ID: 23001798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions.
    Meyer KC; Danoff SK; Lancaster LH; Nathan SD
    Chest; 2015 Jul; 148(1):242-252. PubMed ID: 26149553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment.
    Funke-Chambour M; Azzola A; Adler D; Barazzone-Argiroffo C; Benden C; Boehler A; Bridevaux PO; Brutsche M; Clarenbach CF; Hostettler K; Kleiner-Finger R; Nicod LP; Soccal PM; Tamm M; Geiser T; Lazor R
    Respiration; 2017; 93(5):363-378. PubMed ID: 28343230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity.
    Crestani B
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Sep; 30 Suppl 1():27-32. PubMed ID: 24081241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.
    Jo HE; Prasad JD; Troy LK; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Holland AE; Lake FR; Keir G; Goh NS; Wilsher M; de Boer S; Moodley Y; Grainge C; Whitford HM; Chapman SA; Reynolds PN; Beatson D; Jones LJ; Hopkins P; Allan HM; Glaspole I; Corte TJ
    Med J Aust; 2018 Feb; 208(2):82-88. PubMed ID: 29385965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer in patients with idiopathic pulmonary fibrosis.
    Karampitsakos T; Tzilas V; Tringidou R; Steiropoulos P; Aidinis V; Papiris SA; Bouros D; Tzouvelekis A
    Pulm Pharmacol Ther; 2017 Aug; 45():1-10. PubMed ID: 28377145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum biomarkers in idiopathic pulmonary fibrosis.
    van den Blink B; Wijsenbeek MS; Hoogsteden HC
    Pulm Pharmacol Ther; 2010 Dec; 23(6):515-20. PubMed ID: 20708704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.
    Stainer A; Faverio P; Busnelli S; Catalano M; Della Zoppa M; Marruchella A; Pesci A; Luppi F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis.
    Moran-Mendoza O; Colman R; Kalluri M; Cabalteja C; Harle I
    Expert Rev Respir Med; 2019 Jul; 13(7):601-614. PubMed ID: 31177864
    [No Abstract]   [Full Text] [Related]  

  • 31. [Idiopathic pulmonary fibrosis: from experimental approach to clinic].
    Della Latta V; Del Ry S; Marini C; Morales MA
    Recenti Prog Med; 2013 Nov; 104(11):577-84. PubMed ID: 24336620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment.
    Martinez FJ; Flaherty KR
    Chest; 2017 May; 151(5):1173-1174. PubMed ID: 28483105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [How i treat a patient with idiopathic pulmonary fibrosis].
    Guiot J; Duysinx B; Bonhomme O; Louis R; Corhay JL
    Rev Med Liege; 2017 Sep; 72(9):381-383. PubMed ID: 28892311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis.
    Inchingolo R; Varone F; Sgalla G; Richeldi L
    Expert Rev Respir Med; 2019 Jan; 13(1):39-51. PubMed ID: 30526140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers and their potential functions in idiopathic pulmonary fibrosis.
    Ni S; Song M; Guo W; Guo T; Shen Q; Peng H
    Expert Rev Respir Med; 2020 Jun; 14(6):593-602. PubMed ID: 32187497
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?
    Mahendran S; Sethi T
    QJM; 2012 Oct; 105(10):929-34. PubMed ID: 22647761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers.
    Bartold K; Iskierko Z; Sharma PS; Lin HY; Kutner W
    Biomed J; 2024 Aug; 47(4):100729. PubMed ID: 38657859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.